These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 35154148)

  • 21. Comprehensive profiling of enhancer RNA in stage II/III colorectal cancer defines two prognostic subtypes with implications for immunotherapy.
    Bu X; Liu S; Zhang Z; Wu J; Pan S; Hu Y
    Clin Transl Oncol; 2024 Apr; 26(4):891-904. PubMed ID: 37697139
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Single-cell profiling of the copy-number heterogeneity in colorectal cancer.
    Song S; Feng L; Xi K; Sun Z; Kong D; Luo Z; Pei W; Zhang H
    Chin Med J (Engl); 2023 Mar; 136(6):707-718. PubMed ID: 36914941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Identification of immune-related subtypes of colorectal cancer to improve antitumor immunotherapy.
    Zheng X; Gao Y; Yu C; Fan G; Li P; Zhang M; Yu J; Xu M
    Sci Rep; 2021 Sep; 11(1):19432. PubMed ID: 34593914
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Characterization of anoikis-based molecular heterogeneity in pancreatic cancer and pancreatic neuroendocrine tumor and its association with tumor immune microenvironment and metabolic remodeling.
    Li N; Jia X; Wang Z; Wang K; Qu Z; Chi D; Sun Z; Jiang J; Cui Y; Wang C
    Front Endocrinol (Lausanne); 2023; 14():1153909. PubMed ID: 37234801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The cellular trajectories of tumor-associated macrophages decipher the heterogeneity of pancreatic cancer.
    Lin J; Lu F; Wu Y; Huang H; Pan Y
    Funct Integr Genomics; 2023 Nov; 23(4):343. PubMed ID: 37991591
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Necroptosis throws novel insights on patient classification and treatment strategies for hepatocellular carcinoma.
    Hu B; Gao J; Shi J; Zhang F; Shi C; Wen P; Wang Z; Guo W; Zhang S
    Front Immunol; 2022; 13():970117. PubMed ID: 35967375
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pathogenomics model for personalized medicine in cervical cancer: Cross-talk of gene expressions and pathological images related to oxidative stress.
    Li J; Chen S; Wu J; Liu X; Liu H; Liu Y; Zhu Z
    Environ Toxicol; 2024 Feb; 39(2):751-767. PubMed ID: 37755325
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Multi gene mutation signatures in colorectal cancer patients: predict for the diagnosis, pathological classification, staging and prognosis.
    Zhuang Y; Wang H; Jiang D; Li Y; Feng L; Tian C; Pu M; Wang X; Zhang J; Hu Y; Liu P
    BMC Cancer; 2021 Apr; 21(1):380. PubMed ID: 33836681
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Comprehensive characterization of tumor microenvironment in colorectal cancer via molecular analysis.
    Wu X; Yan H; Qiu M; Qu X; Wang J; Xu S; Zheng Y; Ge M; Yan L; Liang L
    Elife; 2023 Jun; 12():. PubMed ID: 37267125
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Machine learning and bioinformatics analysis revealed classification and potential treatment strategy in stage 3-4 NSCLC patients.
    Li C; Tian C; Zeng Y; Liang J; Yang Q; Gu F; Hu Y; Liu L
    BMC Med Genomics; 2022 Feb; 15(1):33. PubMed ID: 35193578
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A pre-existing population of ZEB2
    Francescangeli F; Contavalli P; De Angelis ML; Careccia S; Signore M; Haas TL; Salaris F; Baiocchi M; Boe A; Giuliani A; Tcheremenskaia O; Pagliuca A; Guardiola O; Minchiotti G; Colace L; Ciardi A; D'Andrea V; La Torre F; Medema J; De Maria R; Zeuner A
    J Exp Clin Cancer Res; 2020 Jan; 39(1):2. PubMed ID: 31910865
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Crosstalk between Mesenchymal Stem Cells and Cancer Stem Cells Reveals a Novel Stemness-Related Signature to Predict Prognosis and Immunotherapy Responses for Bladder Cancer Patients.
    Ma L; Chen H; Yang W; Ji Z
    Int J Mol Sci; 2023 Mar; 24(5):. PubMed ID: 36902193
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Host-microbiota interactions contributing to the heterogeneous tumor microenvironment in colorectal cancer.
    Li X; Wu D; Li Q; Gu J; Gao W; Zhu X; Yin W; Zhu R; Zhu L; Jiao N
    Physiol Genomics; 2024 Feb; 56(2):221-234. PubMed ID: 38073489
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Multi-Omics Characterization of Tumor Microenvironment Heterogeneity and Immunotherapy Resistance Through Cell States-Based Subtyping in Bladder Cancer.
    Hu R; Tao T; Yu L; Ding Q; Zhu G; Peng G; Zheng S; Yang L; Wu S
    Front Cell Dev Biol; 2021; 9():809588. PubMed ID: 35223867
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Integrative Analysis Revealed Stemness Features and a Novel Stemness-Related Classification in Colorectal Cancer Patients.
    Ye ML; Li SQ; Yin YX; Li KZ; Li JL; Hu BL
    Front Cell Dev Biol; 2022; 10():817509. PubMed ID: 35721480
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Molecular classification reveals the diverse genetic and prognostic features of gastric cancer: A multi-omics consensus ensemble clustering.
    Hu X; Wang Z; Wang Q; Chen K; Han Q; Bai S; Du J; Chen W
    Biomed Pharmacother; 2021 Dec; 144():112222. PubMed ID: 34607103
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Subtyping of microsatellite instability-high colorectal cancer.
    Hu W; Yang Y; Qi L; Chen J; Ge W; Zheng S
    Cell Commun Signal; 2019 Jul; 17(1):79. PubMed ID: 31331345
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A next-generation sequencing-based strategy combining microsatellite instability and tumor mutation burden for comprehensive molecular diagnosis of advanced colorectal cancer.
    Xiao J; Li W; Huang Y; Huang M; Li S; Zhai X; Zhao J; Gao C; Xie W; Qin H; Cai S; Bai Y; Lan P; Zou Y
    BMC Cancer; 2021 Mar; 21(1):282. PubMed ID: 33726687
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immune depletion of the methylated phenotype of colon cancer is closely related to resistance to immune checkpoint inhibitors.
    Zhong C; Xie T; Chen L; Zhong X; Li X; Cai X; Chen K; Lan S
    Front Immunol; 2022; 13():983636. PubMed ID: 36159794
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Senescence-based colorectal cancer subtyping reveals distinct molecular characteristics and therapeutic strategies.
    Lv MY; Cai D; Li CH; Chen J; Li G; Hu C; Gai B; Lei J; Lan P; Wu X; He X; Gao F
    MedComm (2020); 2023 Aug; 4(4):e333. PubMed ID: 37502611
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.